24/7 Market News Snapshot 24 February, 2025 – Vivos Therapeutics, Inc. Common Stock (NASDAQ:VVOS)

February 24, 2025

DENVER, Colo., 24 February, 2025 (247marketnews.com) – (NASDAQ:VVOS) are discussed in this article.
Vivos Therapeutics, Inc., a leader in innovative non-invasive therapies for obstructive sleep apnea (OSA), is seeing significant market activity as its stock price rises sharply from an opening of $3.12 to $3.51, reflecting an increase of approximately 12.5%. The surge in share price, along with a trading volume of 826.24K shares, indicates robust investor interest and strong bullish momentum. This heightened activity may signal a continuation of upward trends, making it crucial for investors to monitor key resistance levels.

In tandem with its notable market performance, Vivos has announced an expansion of its strategic alliance model by adding two new facilities in partnership with Rebis Health Holdings. This development follows preliminary data suggesting a marked shift in patient preference, with nearly two-to-one opting for Vivos’ CARE treatment over traditional CPAP methods. The newly operational facilities, set to launch in April, aim to enhance patient access to Vivos’ FDA-cleared treatments and provide comprehensive educational resources about the alternative therapies available.

Recent findings highlight a 64% acceptance rate for Vivos’ treatment, particularly among those dissatisfied with CPAP, which necessitates continuous usage. In contrast, Vivos CARE rehabilitates airway functionality over time, with many patients experiencing symptom relief in just weeks.

As Vivos pursues further strategic partnerships and potential acquisitions, the company’s revenue per case currently averages over $4,700, with gross margins nearing 70%. Kirk Huntsman, Vivos’ Chairman and CEO, remarked on the company’s growth trajectory and commitment to providing significant alternatives to conventional treatments, aiming to transform the landscape of OSA management and ultimately enhance patients’ quality of life.

Related news for (VVOS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.